Just under a third of patients in each group received ACE inhibitors pre‐stroke rising to over a third post‐stroke, and between 20.4% and 37.1% of patients in each group received diuretics pre‐stroke, increasing to between 24.4% and 39.8% post‐stroke. This evidence concerns the gene ACE and stroke disorder.